These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 21735432

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intratympanic gentamicin for Ménière's disease or syndrome.
    Pullens B, van Benthem PP.
    Cochrane Database Syst Rev; 2011 Mar 16; (3):CD008234. PubMed ID: 21412917
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Positive pressure therapy for Ménière's disease or syndrome.
    van Sonsbeek S, Pullens B, van Benthem PP.
    Cochrane Database Syst Rev; 2015 Mar 10; 2015(3):CD008419. PubMed ID: 25756795
    [Abstract] [Full Text] [Related]

  • 5. Intratympanic gentamicin for Ménière's disease.
    Webster KE, Galbraith K, Lee A, Harrington-Benton NA, Judd O, Kaski D, Maarsingh OR, MacKeith S, Ray J, Van Vugt VA, Burton MJ.
    Cochrane Database Syst Rev; 2023 Feb 27; 2(2):CD015246. PubMed ID: 36847592
    [Abstract] [Full Text] [Related]

  • 6. Surgery for Ménière's disease.
    Pullens B, Giard JL, Verschuur HP, van Benthem PP.
    Cochrane Database Syst Rev; 2010 Jan 20; (1):CD005395. PubMed ID: 20091573
    [Abstract] [Full Text] [Related]

  • 7. Intratympanic therapy in Meniere's syndrome or disease: up to date evidence for clinical practice.
    Syed MI, Ilan O, Nassar J, Rutka JA.
    Clin Otolaryngol; 2015 Dec 20; 40(6):682-90. PubMed ID: 25916787
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Control of vertigo in Ménière's disease by intratympanic dexamethasone.
    Weckel A, Marx M, Esteve-Fraysse MJ.
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb 20; 135(1):7-10. PubMed ID: 28760618
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
    Lee SY, Kim YS, Jeong B, Carandang M, Koo JW, Oh SH, Lee JH.
    Am J Otolaryngol; 2021 Feb 20; 42(6):103086. PubMed ID: 34098455
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial.
    Lambert PR, Carey J, Mikulec AA, LeBel C, Otonomy Ménièreʼs Study Group.
    Otol Neurotol; 2016 Dec 20; 37(10):1669-1676. PubMed ID: 27749754
    [Abstract] [Full Text] [Related]

  • 16. Positive pressure therapy for Ménière's disease.
    Webster KE, George B, Galbraith K, Harrington-Benton NA, Judd O, Kaski D, Maarsingh OR, MacKeith S, Ray J, Van Vugt VA, Burton MJ.
    Cochrane Database Syst Rev; 2023 Feb 23; 2(2):CD015248. PubMed ID: 36815713
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome.
    Hussain K, Murdin L, Schilder AG.
    Cochrane Database Syst Rev; 2018 Dec 31; 12(12):CD012173. PubMed ID: 30596397
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.